Mary's story

My contribution to the Arthritis UK Musculoskeletal Advisory Group
"I have only been a Research Partner for a short time (6 months) but I already feel very involved. I am part of the Musculoskeletal Research Advisory Group, and I have attended a conference on osteoarthritis. I was made to feel an important part of these meetings and that my contribution was welcomed. I feel I am still learning, which is no bad thing, about the structure of Arthritis UK, and still finding out new things which I enjoy.
The keeping in touch sessions online are a support and the staff are encouraging. I feel I can ask any question but most importantly I feel my views are valued, even though I am often talking to highly qualified medical professionals.
My personal circumstances are not easy, like many of my fellow Research Partners, as I have both osteoarthritis in my neck and wrists and osteoporosis. I have had two knee replacements which have been brilliant and leave me generally pain free in my knees at least. I am interested all areas of Arthritis UK work and I try and read as much as possible about new research which I hope will benefit the many people who suffer.
Although this is only the beginning of my journey with Arthritis UK, I hope it will be interesting and enlightening."
Osteoarthritis research news
-
Research breakthrough shows hope for millions afflicted by osteoarthritis pain
A discovery led by researchers from the University of Leeds and Leeds Teaching Hospitals NHS Trust (LTHT), and funded by charity Versus Arthritis, could offer hope for millions of people across the UK suffering with chronic pain and stiffness caused by osteoarthritis of the knee.
-
Exploring the link between joint injury and osteoarthritis
Our research is looking at the association between joint injury and the risk of developing osteoarthritis.
-
Preventing osteoarthritis: Unlocking the potential of cell-based therapies
We want to stop osteoarthritis early, before it becomes severe. That's why, our researchers are exploring a revolutionary treatment called cell-based therapy.